Choroid plexus-targeted viral gene therapy for alpha-mannosidosis, a prototypical neurometabolic lysosomal storage disease
Human Molecular Genetics · 20.03.2025 · 34 (7) · 577-585
DOI: 10.1093/hmg/ddae201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 16.01.2025. Verfasst von Eun-Young Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section on Translational Neuroscience, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health…. Hauptthemen laut MEDLINE: Genetic Therapy, Dependovirus, Choroid Plexus, alpha-Mannosidosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH Intramural Bench-to-Bedside Awards, NINDS NIH HHS, Abigail Wexner Research Institute, Nationwide Children's Hospital.
Abstract (Originalsprache)
The choroid plexuses (CP) are highly vascularized structures that project into the ventricles of the vertebrate brain. The polarized epithelia of the CP produce cerebrospinal fluid by transporting water and ions into the ventricles from the blood and normally secrete a large number of proteins. We assessed the feasibility of selective CP transduction with recombinant adeno-associated virus (rAAV) gene therapy vectors for treatment of lysosomal storage disease (LSD), a broad category of neurometabolic illness associated with significant burdens to affected patients and their families. There are no ideal or complete therapeutic options currently available, especially for the central nervous system manifestations of LSDs. Alpha-mannosidosis (AMD) is an autosomal recessive prototypical LSD caused by deficiency of lysosomal alpha-mannosidase and characterized by cerebellar ataxia, neurocognitive disability, facial and skeletal abnormalities, hearing impairment, and mild immune deficiency. In a murine model of AMD, we compared the biochemical effects of CSF-directed rAAV serotypes 1, 4, 5, 6, and 9. Recombinant AAV1 and rAAV6, two closely related serotypes whose capsid sequences differ by only six amino acids, showed the most robust transduction of CP in mouse brain, consistent with their transduction of CPE in nonhuman primates and cats, as well as in other structures. We found restoration of LAMAN enzyme activity comparable to or higher than AMD heterozygote levels in the brain globally (olfactory bulb, cortex, cerebellum, brainstem). Further IND-generating preclinical experiments will advance rAAV6-LAMAN, which appears to be the most promising choroid plexus-targeting candidate serotype for future clinical translation to treat AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section on Translational Neuroscience, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA.
- Research Institute of Children's Hospital of Philadelphia, 502-G Abramson Research Center, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA.
- Center for Gene Therapy, Nationwide Children's Hospital, Abigail Wexner Research Institute, and Department of Pediatrics, The Ohio State University College of Medicine, 575 Children's Crossroad, Columbus, OH 43215, USA.
- Department of Pediatrics, Vagelos College of Physicians & Surgeons, Columbia University, 630 West 168th Street, Room 10-451, New York, NY 10032, USA.
Förderung
- NIH Intramural Bench-to-Bedside Awards
- NINDS NIH HHS
- Abigail Wexner Research Institute, Nationwide Children's Hospital
- NICHD NIH HHS
- Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Abigail Wexner Research Institute, Nationwide Children’s Hospital
Zitieren
APA
Choi, E. Y., Wolfe, J. H., & Kaler, S. G. (2025). Choroid plexus-targeted viral gene therapy for alpha-mannosidosis, a prototypical neurometabolic lysosomal storage disease. Human Molecular Genetics, 34(7), 577-585. https://doi.org/10.1093/hmg/ddae201
Vancouver
Choi EY, Wolfe JH, Kaler SG. Choroid plexus-targeted viral gene therapy for alpha-mannosidosis, a prototypical neurometabolic lysosomal storage disease. Human Molecular Genetics. 2025;34(7):577-585. doi:10.1093/hmg/ddae201
BibTeX
@article{Choi2025,
author = {Choi, Eun-Young and Wolfe, John H and Kaler, Stephen G},
title = {Choroid plexus-targeted viral gene therapy for alpha-mannosidosis, a prototypical neurometabolic lysosomal storage disease},
journal = {Human Molecular Genetics},
year = {2025},
volume = {34},
number = {7},
pages = {577--585},
doi = {10.1093/hmg/ddae201}
}
EUVIMED